you are viewing a single comment's thread.
They upped PT by $2 on P/E analysis. They also raised 2012 and 2013 est .02 and .08. Growth of 4.3% exceeded our 3.5 est. Conversion of strong generics and growth of pharmacy services expected to drive margins thru 2013.
Sentiment: Strong Buy